|
5. Bibliografía
|
[1]
|
MPS. y B.S., Departamento de Alimentación y Nutrición. Encuesta Nacional del Bocio Endémico. Asunción,Paraguay. 1988.
volver
|
|
[2]
|
Baumann E. Uber das normale Vorkommen von Iod in Thierkorper. Hoppe-Seyler’s Z Physiol Chem. 1895; 21:319- 322
volver
|
|
[3]
|
Kendall EC. The isolation in crystalline form of the compound which occurs in the thyroidIts chemical nature and physiologic activity. JAMA 1915, 2042-2064.
volver
|
|
[4]
|
Hurington CR. Chemistry of thyroxine. II Constitution and synthesis of desiodo-thyroxine. Biochem J. 1926; 20:300-305.
volver
|
|
[5]
|
Marine D. Quantitative studies on the in vivo absorption of iodine by dog’s thyroid glands. J.Biol Chem. 1915; 22:547-552.
volver
|
|
[6]
|
Wartofsky L; Burman Kd. Alterations in thyroid function in patients with systemic illness; the “euthyroid sick syndrome.” Endocr Rev 1982; 3:164-168.
volver
|
|
[7]
|
Danforth E; Burger AG. The impact of nutrition on thyroid hormone physiology abduction. Ann Rev Nutr 1989; 9:201-204.
volver
|
|
[8]
|
Namba H; Yamashita S ,Kimura H, et alEvidence of thyroid volume increase in normal subjects receiving excess iodideJ.Clin Endocrinol Metab 1993; 76:605-607.
volver
|
|
[9]
|
Woeber KA. Iodine and thyroid diseaseMed Clin North Am 1991; 75:169-173.
volver
|
|
[10]
|
Arntzenius AB, Smit LJ, Schipper J et al. Inverse relation between iodine intake and thyroid blood flow; color Doppler flow imaging in euthyroidism humansJ Clin Endocrol Metab 1991; 73:1051-1054.
volver
|
|
[11]
|
Método Elisa (MEIA), DRG, Alemania.
volver
|
|
[12]
|
Barker S. B: Physiological activity of thyroid hormone an analogues. In Pitt-Rivers R, Trotter WR (eds): The Thyroid GlandLondon, Butterworths, 1964, pp, 199-236.
volver
|
|
[13]
|
Leonard JL, Kaplan MM, Visser Tj, et al: Cerebral Cortex responds rapidly to thyroid hormones. Science 1981, 214: 571-573.
volver
|
|
[14]
|
Graves RJ. Newly observed afectation of the thyroid gland in females.Long Med Surg J 1835; 7:517-520.
volver
|
|
[15]
|
Forrest, D., Erway, L. C., Ng, L., Altschuler, R., & Curran, T. 1996. Nat. Genet. 13, 354.
volver
|
|
[16]
|
Shibusawa, N. et al.2003. Thyroid hormone action in the absence of thyroid hormone receptor DNA-binding in vivoJ. Clin. Invest. 112:588-597.
volver
|
|
[17]
|
Fabricio Monaco, Clinical Perspective, Classification of thyroid diseases: Suggestions for a revision.The Journal of Clinical Endocrinol & Metab. April 2003, 88 (4):1428-1432.
volver
|
|
[18]
|
Gloss, B., Trost, S., Bluhm, W., Swanson, E., Clark, R., Winkfein, R., Janzen, K., Giles, W., Chassande, O., Samarut, J., & Dillmann, W. (2001). Endocrinology 142, 544-550.
volver
|
|
[19]
|
Gauthier, K., Plateroti, M., Harvey, C. B., Williams, G. R., Weiss, R. E., Refetoff, S., Willott, J. F., Sundin, V., Roux, J. P., Malaval, L., et al(2001). Mol. Cell. Biol. 21, 4748- 4760.
volver
|
|
[20]
|
Fabricio Monaco, Clinical Perspective, Classification of thyroid diseases: Suggestions for a revision.The Journal of Clinical Endocrinol & MetabApril 2003, 88 (4):1428-1432.
volver
|
|
[21]
|
Adams DD, Purves HD. Abnormal responses in the assay of thyrotrophinProc Univ Otago Md Sch 1956; 34:11-22.
volver
|
|
[22]
|
Kriss JP, Pleshakov V, Chien JRIsolation and identification of the long-acting thyroid stimulator an its relation to hyperthyroidism and circumscribed pretibial myxedema. J. Clin Endocrinol 1964; 24:1005-1028.
volver
|
|
[23]
|
Rapoport B, Chazenbalk GD, Jaime JC, Mc Lachlan SM. The thyrotrophin (TSH) receptor: interaction with TSH and autoantibodies.Endocr Rev 1998; 19:673-716 [Erratum, Endocr Rev 1999; 20:100.]
volver
|
|
[24]
|
Weetman AP, DeGroot L. Autoimmunity to the thyroid gland. In: Thyroid disease manager. Chicago: Endocrine Education, 1999. http//www.thyroidmanager.org -NAPS document n° 05570 for 30 pages, c/o Microfiche Publications, 248 Hempstead Tpke, West Hempstead, NY 11552.
volver
|
|
[25]
|
Vanderpump MPJ, Tunbridge WMG. The epidemiology of autoimmune thyroid disease. In: Volpé R, ed.Autoimmune endocrinopathies.Vol. 15 of Contemporary endocrinology.Totowa, N.J.: Humana Press, 1999:141-162.
volver
|
|
[26]
|
Jacobson DL, Gange SI, Rose NR, Graham NM.Epidemiology and estimated population burden of selected autoimmune diseases in the United StatusClin Immunol Immunopathol 1997;84:223-243.
volver
|
|
[27]
|
Chiovato L,Pinchera L.Stress ful life events and Graves’ disease.Euro J. Endocrinol (Osf) 1994;40:759-764.
volver
|
|
[28]
|
Bartalena L, Bogáis F, Tanda ML, Manetti L, Dell’Unto E, Martino E, Cigarette smoking and the thyroid. Eur J. Endocrinol 19995; 133:507-512.
volver
|
|
[29]
|
Henzen C, Buess M, Brander Iodine-induced hyperthyroidism iodine-induced Basedow's disease.Schweiz Med Wochenschr.German,1999 May 1;129(17):658-664.
volver
|
|
[30]
|
Ermans AM, Camus M.Modification of thyroid function induced by chronic administration of iodine inthe presence of autonomous thyroid tissue.Acta Endocrinol (Copen)1972;70:463.
volver
|
|
[31]
|
Barclay ML, Brownlie BEW, Turner JG, Wells JE. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol (Oxf) 1994; 40:759-764.
volver
|
|
[32]
|
Shapiro SJ, Friedman NB, Perzik SL, Catz B Incidence of Thyroid carcinoma in Graves DiseaseCancer 1970; 26:1261-1270.
volver
|
|
[33]
|
Hamilton JG., Lawrence JH. Recent clinical development in the therapeutic application of radio-phosphorus and radioiodine |abstract| J Clin Invest 1942; 21:6244-6245.
volver
|
|
[34]
|
Saúl Hertz, Arthur Roberts.El Yodo Radioactivo en el estudio de la fisiología tiroidea, El uso del Yodo Radioactivo en la Terapia del hipertiroidismo; JAMA (11 Mayo)1946;131:81-85.
volver
|
|
[35]
|
Matin P, Clinical Nuclear Medicine, Medical Outline Series, Medical Examination Publishing Co, March 1981.pp.258-278.
volver
|
|
[36]
|
Earle M. Chapman, Robley D. EvansEl Tratamiento del Hipertiroidismo con Yodo Radioactivo, (11 Mayo) JAMA 1946; 131:86-88.
volver
|
|
[37]
|
Means JH The use of radioactive iodine in the diagnosis and treatment of thyroid diseases. Bull N Y Acad Med. 1948;24:273-277.
volver
|
|
[38]
|
Sugrue M, Mc Evoy M, Feely J., and Drury I, hyperthyroidism in the Land of Graves: Results of Treatment by Surgery, Radio-iodine and Carbimazole, 837 casesQuarterly Journal of Medicine, New Series XLIX, Winter, 1980.pp 51-61.
volver
|
|
[39]
|
Levy EG. Treatment of Graves' disease: The American wayBaillieres Clin Endocrinol Metab 1997; 11:585-595.
volver
|
|
[40]
|
Rodas Gauto, Jorge Hernán: Tesis Doctoral, Análisis costo –beneficio de la colecistectomía convencional versus colecistectomía video-laparoscópica, año 2002,pág. 47- 48.
volver
|
|
[41]
|
Ward LS, Castelo Filho A, Menalo E, Ribeiro SR, Lima MC, Maciel RM, Relación Costo Efectividad de procedimientos en el tratamiento de la enfermedad de Graves. Rev. Ass. Med Brasil1986, 32: 147-154.
volver
|
|
[42]
|
Ljunggren J-G, Törring O, Wallin G, et al. Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized studyThyroid 1998; 8:653-659.
volver
|
|
[43]
|
Sanabria Ludbarda, Tesis Doctoral, Pre y Post Operatorio de las Tiroidectomías por Tirotoxicosis en el Hospital de Clínicas 1985-1995, Asunción 1998, Paraguay.
volver
|
|
[44]
|
Jara Yorg J.A., Martínez J., Moreno Azorero R., Cabañas F., Zarate J., Spaini C., Chaparro N., Ovelar A. “Graves Disease and Toxic Adenoma Treated with I-131 in Paraguay. Libro Instituto de Investigaciones en Ciencias de la Salud, Tomo II, EDUNA, 1996, pag 338-345.
volver
|
|
[45]
|
De Groot L.J.Thyroid and the heartMayo Clin. Proc. 1972; 47:865-871.
volver
|
|
[46]
|
Larsen PR, Ingbars S.H. The thyroid-gland Disease En: Wilson J.D. Foster D.W., BTH ed Saunders Co. Philadelfia 1992 :( 2)433-434.
volver
|
|
[47]
|
Wartofky L, Glinoer D, Solomon B et alDifferences and similarities in the diagnosis and treatment of Graves Disease in Europe, Japan and the United StatesThyroid 1991, 1:129-135.
volver
|
|
[48]
|
Joshephine N, Rini, Shankar vallabhajosula, Pat Zanzonico, James R. Hurley, David V. Becker, and Standley J. Goldsmith Thyroid uptake of liquid versus capsule 131 I tracers in Hyperthyroidism patients treated with liquid 131 I.Thyroid, 1999, Volume 9, Number 4, Pag. 347-352.
volver
|
|
[49]
|
Braga M, Walpert N, Burch HB, Solomon BL, Cooper DS. The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trialThyroid 2002, Feb; 12(2) 135-139.
volver
|
|
[50]
|
Roudebush CP, Hoye FE, DeGroot LJ. Compensated low –dose 131I therapy of Grave’s diseaseAm Intern Med 1977; 87:441-443.
volver
|
|
[51]
|
Watson AB, Browglie BFW, Frampton CM Turner JG, Rogers TGH. Outcome following standardized 185 Mbq dose 131I therapy for Grave’s disease. Clin Endocrinol (Oxf) 1988; 28:187-198.
volver
|
|
[52]
|
Sabri O, Zimny M, Schreckenberger M, Reinartz P, Ostwald E, Buell U. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without Carbimazole at the time of radioiodine therapy. Thyroid.1999 Dec; 9(12):1181-1188.
volver
|
|
[53]
|
H.B. Burch, B.L. Solomon, D.S. Cooper, P. Ferguson, N. Walpert and R. Howard Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Grave’s hyperthyroidism. J Clin Endocrinol Metab 1999 Nov; 84(11):4012-4016.
volver
|
|
[54]
|
Vickery AL, Wang CA, Walter AM, 1990 Treatment of intrathyroidal papillary carcinoma of the Thyroid .Cancer 60:2587-2595.
volver
|
|
[55]
|
Nogushi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H 1996 Small carcinomas of the thyroidArch Surg 131:187-191.
volver
|
|
[56]
|
Suhail AR Doi,Issa Loutfi and Kamal AS AL-Shoumer: A mathematical model of optimized radioiodine-131 therapy of Graves´ hyperthyroidism.BMC Nuclear Medicine 2001, 1:1-5.
volver
|
|
[57]
|
Hay ID, Grant CS, Van Heerden JA 1992 Papillary microcarcinoma: A study of 553 cases observed in 50 year periodSurgery 112:1139-1147.
volver
|
|
[58]
|
Chapman EM, Maloof P.: The use of radioactive iodine in the diagnosis and treatment of hyperthyroidism.Ten years´ experience.Medicine 1955,34:261-264.
volver
|
|
[59]
|
Kendall-Taylor P, Kleir MJ, Ross WM: Ablative radioiodine therapy for hyperthyrodism: Long term follow-up studyBr Med J 1984,289:361-363.
volver
|
|
[60]
|
Holm LE, Lundell G, Israelsson A, Dahlquist I. Incidence of hypothyroidism long after iodine-131 therapy for hyperthyroidism. J. Nucl Med 1982; 23:103-107.
volver
|
|
[61]
|
Tigas S, Idiculla J, Beckett G, Toft A. Is excessive weight gain altering ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy? Thyroid 2000 Dec.:10(12):1107-1111.
volver
|
|
[62]
|
Dobyns BM, Sheline GE, Workman JB, Edythalena AT, Mc Conahey WM, Becker DU. 1974 Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: A report of the cooperative thyrotoxicosis therapy follow-up study J Clin Endocrinol Metab 38:976-998.
volver
|
|
[63]
|
Peters H., Fisher C., Bogner U., Reiners C., Schleusener H., Reduction in thyroid volume after radioiodine therapy of Grave’s hyperthyroidism: results of a prospective, randomized, multicentre studyEuropean Journal of Clinical Investigation 26(1):56-63, January 1996 173.
volver
|
|
[64]
|
Grigsby PW, Siegel BL, Baker S, Eichling JO. Radiation exposure from out patient radioactive iodine (I131) therapy for thyroid carcinomaJama 2000 May: 3:283(17)2272-2274.
volver
|
|
[65]
|
Paccini F, DiCascio PC, Anelli S, Macchia E, Concetti R, Miccoli P, Arganini M, Pinchera A, Thyroid carcinoma in thyrotoxicosis patients treated by surgery. J Endocrinol Invest 1998; 11:107-112.
volver
|
|
[66]
|
Miller M, Robert B. Thyrod carcinoma occurring in Graves’ diseaseArch Intern Med 1966; 117:432-435.
volver
|
|
[67]
|
Carnell Eric, and. Valiente William A Thyroid Nodules in Graves’ disease: Classification, Characterization, and Response to treatmentNThyroid, Volume 8, Number 7, 1998, 571-582.
volver
|
|
[68]
|
Ozaki C, Ito K, Kobayashi K, Toshima K, Iwasaki H, Yashiro T. Thyroid carcinoma in Graves’ diseaseWorld J. Surj 1990; 14(3): 437-444.
volver
|
|
[69]
|
Marine D, Lenhart CH. Pathological anatomy of exophtalmic goiter.Arch Intern Med 1991;8:265-316.
volver
|
|
[70]
|
Charkes ND, Graves’ disease with functioning nodules (Marine-Lenhart Syndrome) J. Nucl Med 1972; 13(12):885-892.
volver
|
|
[71]
|
Nortdyke RA, Gilbert EL Jr, Optimal iodine-131 dose for eliminating hyperthyroidism in Grave’s disease. J. Nucl Med 1991; 32:411-416.
volver
|
|
[72]
|
Mazzaferri EL, Managment of a solitary thyroid nodule. N Engl J Med, 1993; 328-553.
volver
|
|
[73]
|
Nuggard B, Hegedus L, Nielsen KG, Ulriksen P, Hansen JM. Long term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin.Endocrinol(Oxford)1999 Febr.;50(2):197-202.
volver
|
|
[74]
|
Kraiem Z, Glaser B, Sigla J, Pauker J, Sadeh O, Sheffield M, 1987 Toxic multinodular goiter: A variant of autoimmune huperthyroidism. J Clin Endocrinol Metab 65(4):659-664.
volver
|
|
[75]
|
Sharon Wallace Stara, RN, DNS(c), APN-C: Clinical Issues Related to HyperthyroidismClinical Excellence for Nurse Practicioners. 2002,N°4, Vol 6,24-28.
volver
|
|
[76]
|
Jara Yorg J.A., Martinez J,Moreno Agorero R, Cabañas F,Zarate J.,Spaini C., Chaparro N.,Ovelar A.: Grave’s Disease And Toxic Adenoma Treated With I - 131 In Paraguay, Libro del Instituto de Investigaciones en Ciencias de la Salud, EDUNA-EFACIM,Patología Tiroidea 1995, Pág. 338-368.
volver
|
|
[77]
|
Nygaard B, Hegedus L, Servil N, Hjalgrim H, Hansen BM, Soe-Jensen, P Hansen JM: Influence of compensated radioiodine therapy on thyroid volume and incidente of hypothyroidism in Graves disease.J Intern Med 1995, 238: 491-497.
volver
|
|
[78]
|
Leslie De Groot, Textbook of Endocrinology, Third edition, 1995, Vol 1, Page 823-825.
volver
|
|
[79]
|
Hays MT: Hypothyroidism following iodine-131 therapyJ Nucl Med 1982, 23: 176-179.
volver
|
|
[80]
|
Weetman A, Grave’s Disease: N Engl J Med October 26, 2000. pp.1239-1242.
volver
|
|
[81]
|
Smith RN, Wilson GM: Clinical trials of different doses of 131I treatment of thyrotoxicosis. Br Med J 1967, 1: 129-132.
volver
|
|
|
